PLEASANTON, Calif., June 4, 2015 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has provided 510(k) clearance for the cobas® HSV 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback